Rigel Pharmaceuticals, Inc. (RIGL)
29.12
+0.30
(+1.04%)
USD |
NASDAQ |
May 21, 16:00
29.12
0.00 (0.00%)
After-Hours: 19:59
Rigel Pharmaceuticals Research and Development Expense (TTM) : 36.54M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Arvinas, Inc. | 252.10M |
| Pfizer Inc. | 10.52B |
| Amgen, Inc. | 7.514B |
| Madrigal Pharmaceuticals, Inc. | 451.53M |
| Xencor, Inc. | 245.52M |